Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Selective endothelin ETB receptor antagonists disclosed by Shionogi

Aug. 24, 1999

Academic team identifies novel modulators of cholinergic function

Aug. 23, 1999

ICAgen researchers patent new potassium channel blockers

Aug. 23, 1999

WHI-P164, a potential treatment for atherosclerosis in patients with hyperlipidemia, hypertension

Aug. 23, 1999

CV Therapeutics reports initial results from ranolazine trial

Aug. 23, 1999

Selective ETB receptor antagonist identified by Abbott

Aug. 18, 1999

Results of canine study support conivaptan efficacy in CHF

Aug. 18, 1999

Cordox shows cardioprotective effect during prolonged ischemia

Aug. 17, 1999

Endovasc reaches liposomal VEGF development agreement with Hermes Biosciences

Aug. 17, 1999

ACES will evaluate azithromycin in heart disease

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...